Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Márcio Debiasi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Sao Paulo Medical Journal = Revista Paulista De Medicina|February 11, 2011
Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomyMárcio Debiasi, Marluce Hehnemann, Bernardo Garicochea
The Lancet. Oncology|May 3, 2019
Denosumab in early-stage breast cancerMariana Brandão, Márcio Debiasi, Evandro de Azambuja
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2011
Is the study power enough to say "no difference"?Guilherme Geib, Márcio Debiasi, Nemora T Barcellos, et al.
Jornal De Pediatria|June 15, 2006
Inhaled corticosteroid treatment and growth of asthmatic children seen at outpatient clinicsElisete E Arend, Gilberto B Fischer, Márcio Debiasi, et al.
Cancers|May 13, 2023
PET/CT in Patients with Breast Cancer Treated with ImmunotherapySofia C Vaz, Stephanie L Graff, Arlindo R Ferreira, et al.
Journal of Global Oncology|July 19, 2017
Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health SystemMárcio Debiasi, Tomás Reinert, Rafael Kaliks, et al.
ESMO Open|August 28, 2020
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysisMariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, et al.
Clinical Genitourinary Cancer|April 19, 2020
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysisFernando Sabino M Monteiro, Andrey Soares, Márcio Debiasi, et al.
Frontiers in Oncology|June 7, 2018
Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-AnalysisMárcio Debiasi, Carisi A Polanczyk, Patrícia Ziegelmann, et al.
BMC Cancer|January 5, 2019
PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114)Gustavo Werutsky, Bruno Hochhegger, José Antônio Lopes de Figueiredo Pinto, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Sao Paulo Medical Journal = Revista Paulista De Medicina|February 11, 2011
Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomyMárcio Debiasi, Marluce Hehnemann, Bernardo Garicochea
The Lancet. Oncology|May 3, 2019
Denosumab in early-stage breast cancerMariana Brandão, Márcio Debiasi, Evandro de Azambuja
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2011
Is the study power enough to say "no difference"?Guilherme Geib, Márcio Debiasi, Nemora T Barcellos, et al.
Jornal De Pediatria|June 15, 2006
Inhaled corticosteroid treatment and growth of asthmatic children seen at outpatient clinicsElisete E Arend, Gilberto B Fischer, Márcio Debiasi, et al.
Cancers|May 13, 2023
PET/CT in Patients with Breast Cancer Treated with ImmunotherapySofia C Vaz, Stephanie L Graff, Arlindo R Ferreira, et al.
Journal of Global Oncology|July 19, 2017
Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health SystemMárcio Debiasi, Tomás Reinert, Rafael Kaliks, et al.
ESMO Open|August 28, 2020
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysisMariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, et al.
Clinical Genitourinary Cancer|April 19, 2020
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysisFernando Sabino M Monteiro, Andrey Soares, Márcio Debiasi, et al.
Frontiers in Oncology|June 7, 2018
Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-AnalysisMárcio Debiasi, Carisi A Polanczyk, Patrícia Ziegelmann, et al.
BMC Cancer|January 5, 2019
PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114)Gustavo Werutsky, Bruno Hochhegger, José Antônio Lopes de Figueiredo Pinto, et al.
Pageof 2